Senores Pharmaceuticals Limited
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| SENORES.NS | SANOFI.BO | AZN | NVS | SOLARA.NS | 1795.TW | |
|---|---|---|---|---|---|---|
| Market cap | 54.71B | 77.83B | 293.14B | 311.59B | 31.04B | 44.76B |
| P/E (TTM) | 39.0 | 21.4 | 26.7 | 31.5 | 83.4 | 11.8 |
| Forward P/E | 25.5 | 19.0 | 16.7 | 16.6 | 20.5 | 7.1 |
| Price/book | 5.3 | 9.4 | 5.7 | 8.4 | 2.2 | 1.9 |
| Dividend yield | — | 3.56% | 1.69% | 2.87% | — | 1.61% |
| 1-year change | +41.27% | −27.27% | +12.81% | +30.35% | +14.61% | −42.88% |
| Today | +4.48% | +0.11% | +2.79% | +3.59% | −0.25% | +5.66% |
The closest companies by business and industry (Drug Manufacturers - General). Prices may be delayed up to 20 min.
Latest news
All SENORES.NS news ›Senores Pharmaceuticals Sees Strong Q2 FY27 With 25% Revenue Jump, EBITDA Climbing 38% Amidst Portfolio Expansion
Mumbai: Senores Pharmaceuticals Limited on Wednesday, 29 October 2026, reported its unaudited financial results for the quarter and half year ended 30 September 2026. The company's revenue for the second quarter of fiscal year 2027 grew by…
Senores Pharmaceuticals SENORES Postal Ballot MD Re-appointment
Kalkine India Senores Pharmaceuticals (NSE:SENORES): Who Is Being Put to Shareholder Vote? Source: Krish Capital Pty Ltd Senores Pharmaceuticals Limited (NSE:SENORES) filed a Postal Ballot Notice on 16 October 2026, seeking shareholder
Senores Pharmaceuticals seeks approval for MD and WTD re-appointments
Senores Pharmaceuticals Limited has issued a postal ballot notice seeking shareholder approval for the re-appointment of its top leadership. The resolutions concern the continuation of Swapnil Jatinbhai Shah as Managing Director and Chetan…
Senores Pharmaceuticals reappoints key directors for three-year terms
Business Upturn Senores Pharmaceuticals reappoints key directors for three-year terms Senores Pharmaceuticals Limited has announced the reappointment of two of its key executives, Mr. Swapnil Jatinbhai Shah and Mr. Chetan Bipinch
Senores Pharmaceuticals vs Nifty 50: 1Y Return +80.29% vs -10.93%
Senores Pharmaceuticals share price Rs 1,320.00 on NSE. Senores Pharmaceuticals vs Nifty 50 over 1 year: +80.29% vs -10.93%. 52-week high Rs 1,599.00, low Rs 705.10. Senores Pharmaceuticals vs Nifty 50 is a comparison that looks different…
Is Senores Pharmaceuticals the Best Stock in Its Sector? A Look at the Numbers
Senores Pharmaceuticals CMP Rs 1,401 (07 Oct 2026). Market cap Rs 6,389 Cr. ROE 12.36%. P/E 48.83x versus Industry P/E 37.19x. Is Senores Pharmaceuticals the best stock in its sector? The stock trades on the NSE at Rs 1,401 as of 07…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- univest.in2
- businessupturn.com1
- freepressjournal.in1
- kalkine.co.in1
- scanx.trade1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 6 articles, not a forecast.